• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Eastern Mediterranean Health Journal: Al-Magallat al-Sihhiyyat li-Sarq al-Mutawassit >Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran
【24h】

Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran

机译：经济制裁对伊朗伊斯兰共和国获取非传染性疾病药物的影响

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background : It has been argued that economic sanctions and the economic crisis have adversely affected access to drugs. Aim : To assess the impact of economic sanctions on the Iranian banking system in 2011 and Central Bank in 2012 on access to and use of drugs for noncommunicable diseases (NCDs). Methods : An interrupted time series study assessed the effects of sanctions on drugs for diabetes (5 drug groups), asthma (5 drug groups), cancer (14 drugs) and multiple sclerosis (2 drugs). We extracted data from national reference databases on the list of drugs on the Iranian pharmaceutical market before 2011 for each selected NCD and their monthly sales. For cancer drugs, we used stratified random sampling by volume and value of sales, and source of supply (domestic or imported). Data were analysed monthly from 2008 to 2013. Results : Market availability of 13 of 26 drugs was significantly reduced. Ten other drugs showed nonsignificant reductions in their market availability. Interferon α2b usage reduced from 0.014 defined daily doses per 1000 inhabitants per day (DID) in 2010 to 0.008 in 2013; and cytarabine from 1.40 mg per 1000 population per day in 2010 to 0.96 in 2013. Selective β2-adrenoreceptor agonists usage reduced from 8.4 to 6.8 DID in the same time period. Conclusion : There is strong evidence that sanctions have had a negative effect on access to drugs, particularly those that depended on the import of their raw material or finished products.
机译：背景：有人认为，经济制裁和经济危机对获取毒品有不利影响。目的：评估经济制裁对2011年伊朗银行体系和2012年中央银行对获取和使用非传染性疾病药物的影响。方法：一项中断时间序列研究评估了制裁对糖尿病药物（5个药物组），哮喘（5个药物组），癌症（14个药物）和多发性硬化症（2个药物）的影响。我们从国家参考数据库中提取了2011年之前伊朗药品市场上药品清单中每个选定的非传染性疾病及其每月销售额的数据。对于癌症药物，我们使用了按数量和销售价值以及供应来源（国内或进口）分类的随机抽样。从2008年至2013年，每月进行数据分析。结果：26种药物中有13种的市场可获得性大大降低。其他十种药物的市场可利用性没有明显下降。干扰素α2b的使用量从2010年的每千居民每日0.014规定的每日剂量（DID）降低至2013年的0.008;和阿糖胞苷的比例从2010年的每1000人口每天1.40 mg减少到2013年的0.96。β2-肾上腺素受体激动剂的选择性使用在同一时期从8.4 DID降低到6.8 DID。结论：有充分的证据表明，制裁对获取药物有不利影响，特别是那些依赖于原材料或制成品进口的制裁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号